Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact on Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor Faldaprevir

  • Kristi L. Berger, Ibtissem Triki, Mireille Cartier, Martin Marquis, Marie-Josée Massariol, Wulf O. Böcher, Yakov Datsenko, Gerhard Steinmann, Joseph Scherer, Jerry O. Stern, George Kukolj
  • Antimicrobial Agents and Chemotherapy, November 2013, ASM Journals
  • DOI: 10.1128/aac.01976-13

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1128/aac.01976-13